Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 31 recruiting now early-phase tilt #105 of 28,707 conditions

Weight Loss: early-phase trial registry

31 of 119 indexed Weight Loss trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #105 of 28,707 conditions by registered trial count.

119 US clinical trials · 31 currently recruiting · #105 of 28,707 conditions by registered trial count

Weight Loss: 119 US clinical trials tracked, 31 recruiting.

Weight Loss is the subject of 119 registered US clinical trials on ClinicalTrials.gov, 31 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Drexel University, running 4 of these trials.

Enrollment posture brief

Registry condition weight-loss

OPEN 31 | RECR 26% | LATE 5 | EARLY 15 | RANK #105 | SPON 4

Nearest open-share peer: Barrett's Esophagus (26% recruiting · 23 trials)

Triple Negative Breast Cance57.1%Healthy Participants35%Postoperative Pain34.7%Diabetes Mellitus, Type 132.8%Weight Loss (this)26%
Open-enrollment share among volume-matched conditions near Weight Loss

Weight Loss lists 31 open slots (26% of 119 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Weight Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Weight Loss is recruiting below its size-band peers.

    31 of 119 indexed trials (26.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Weight Loss trials is spread across many organizations.

    Drexel University accounts for 4 of 119 trials (3.4%). 85 distinct sponsors appear on at least one study for this condition label.

  3. Typical Weight Loss enrolment sits around 79 participants.

    Median target enrolment is 79 among the 117 trials that report a genuine target (sentinel values excluded). 66 of those (56.4%) plan for fewer than 100 participants.

  4. Weight Loss research is mostly interventional.

    107 interventional and 12 observational studies make up this index (89.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 212Phase 32Phase 43

Open and recent trials

119 total, page 3 of 3

COMPLETED NA 37 participants

Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.

Ohio State University

NCT06449287

COMPLETED Phase 2 34 participants

Topiramate in Adolescents With Severe Obesity

University of Minnesota

NCT01859013

COMPLETED NA 33 participants

Bariatric Scalable Internet Treatments

Yale University

NCT03680703

COMPLETED Phase 2 32 participants

Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers

Raziel Therapeutics

NCT03171415

COMPLETED 32 participants

Sleep During Weight Loss and Weight Loss Maintenance

Dartmouth-Hitchcock Medical Center

NCT03774563

COMPLETED NA 32 participants

Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention

Stanford University

NCT05715242

COMPLETED NA 31 participants

Time Restricted Feeding for Weight Loss and Cardio-protection

University of Illinois at Chicago

NCT02948517

COMPLETED NA 30 participants

Individualized Diet Improvement Program for Weight Loss and Maintenance, Cohort 2

University of Illinois at Urbana-Champaign

NCT04605640

COMPLETED NA 30 participants

Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors

Noom

NCT04753268

COMPLETED 27 participants

Role Of Metabolic Adaptation In Weight Regain

Pennington Biomedical Research Center

NCT05766358

COMPLETED NA 26 participants

TOPS for African American Breast Cancer Survivors

Duke University

NCT04741802

COMPLETED Phase 2 25 participants

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Wake Forest University Health Sciences

NCT02301416

COMPLETED Phase 1 24 participants

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

University of Colorado, Denver

NCT03620773

COMPLETED NA 19 participants

A Study of a Values-Based Intervention to Promote Weight Loss

Drexel University

NCT03991676

COMPLETED NA 15 participants

A Virtual-reality Based Approach to Improve Behavioral Weight Management Outcomes

California Polytechnic State University-San Luis Obispo

NCT04534088

COMPLETED NA 12 participants

The Effects of Alcohol Consumption on Central Adiposity

Pennington Biomedical Research Center

NCT03521817

COMPLETED NA 12 participants

PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia

University of California, San Diego

NCT01171599

COMPLETED NA 8 participants

Timing of Meals for Weight Loss

The University of Tennessee, Knoxville

NCT02204735

COMPLETED NA

Dietary Pork, Appetite and Weight Loss in Human

Purdue University

NCT01006343

← Previous Page 3 of 3

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 12
Phase 3 2
Phase 4 3

Named interventions

Most-linked intervention names on Weight Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
5 trials
VK2735 Drug
3 trials
HH Behavioral
2 trials
Continuous Glucose Monitor Device Device
2 trials
Calorie Restriction Behavioral
2 trials
Laboratory Biomarker Analysis Other
2 trials
Placebo Other
2 trials
Tirzepatide Drug
2 trials

US sites by state

Facility locations filed on Weight Loss trials. A trial with sites in several states counts in each.

California 17 trials
Pennsylvania 13 trials
New York 13 trials
Texas 11 trials
North Carolina 9 trials
Massachusetts 8 trials
Illinois 7 trials
Tennessee 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Weight Loss page

119 registered trials, 31 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Weight Loss condition card totals 119 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.